TAILIEUCHUNG - Consolidated financial summary (forthe first half ended september 30,2012)

This press release includes the financial measures revenues excluding traffic acquisition costs, operating income before depreciation and amortization and free cash flow. These measures are defined as non-GAAP financial measures by the Securities and Exchange Commission and may be different from non-GAAP financial measures used by other companies. The presentation of this financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with generally accepted accounting principles. See Note to Unaudited Condensed Consolidated Statements of Operations and Reconciliations to Unaudited Condensed Consolidated Statements. | October 29 2012 Consolidated Financial Summary For the First Half Ended September 30 2012 Listed company Hitachi Chemical Co. Ltd. Code number 4217 Stock exchange Tokyo and Osaka URL http Representative Kazuyuki Tanaka Position of the person President Chief Executive Officer and Director Person in charge of the reference Atsushi Kato Position of the person Manager Corporate Communication Center CSR Management Sector Tel 81-3-5381-2370 Date of the release of quarterly report schedule November 13 2012 Date of the start of dividend payment November 28 2012 Creates supplemental explanatory materials for quarterly financial summaries Yes Holds quarterly financial results meeting Yes for investment analysts and institutional investors Amounts rounded to the nearest million yen 1. Consolidated Financial Highlights for the First Half Ended September 30 2012 April 1 2012 through September 30 2012 1 Consolidated Financial Results indicates the rate of - compared with the same term of previous fiscal year Net Sales Operating Income Ordinary Income Net Income First half ended Million yen Million yen Million yen Million yen September 30 2012 234 043 13 4o1 13 483 9 001 September 30 2011 240 446 15 767 15 909 8 307 Note Comprehensive income April 1 2012 through September 30 2012 4 622 million yen April 1 2011 through September 30 2011 1 607 million yen Net Income per Share Basic Net Income per Share Diluted First half ended Yen Yen September 30 2012 - September 30 2011 - 2 Consolidated Financial Position Total Assets Total Net Assets Net Worth Ratio Million yen Million yen As of Sep. 30 2012 440 869 287 967 As of March 31 2012 440 981 287 239 Reference Stockholders equity As of September 30 2012 283 849 million yen As of March 2012 283 079 million yen 2. Dividend Dividend per Share 1st Quarter 2nd Quarter 3rd Quarter Year-End Total March 2012 March 2013 Yen - Yen Yen Yen .

• Tài chính doanh nghiệp
• neurotransmitter
• glutamate
• sufficiently many neurons
• decisions about medicines
• Supporting adherence
• Reviewing medicine
• trình bày báo cáo
• tài liệu báo cáo khoa học
• báo cáo y học
• kiến thức y học
• nghiên cứu y học
• Replication Termination
• Aggregatibacter actinomycetemcomitans
• Receptor Function
• Venom Secreted
• Phospholipases A2
• Neurotransmitter Transporters
• Cryopreserved Semen
• Chemical Features
• Non Conventional Fruits
• Pathogenic microorganisms
• defense mechanisms
• microorganisms and trigger